MFS
DYN icon

Mirabella Financial Services’s Dyne Therapeutics DYN Stock Holding History

Mirabella Financial Services’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,698
Closed -$201K – 257
2024
Q2 		$201K Buy
+5,698
New +$166K 0.01% 394
2020
Q4 		– Sell
-27,558
Closed -$556K – 357
2020
Q3 		$556K Buy
+27,558
New +$605K 0.08% 128

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Mirabella Financial Services's DYN Position: Q3 2024 in Review

Mirabella Financial Services sold out of Dyne Therapeutics (DYN) in Q3 2024, closing a stake of 5,698 shares — an estimated $201K sold.

Mirabella Financial Services first reported a position in DYN in Q3 2020 and held it in 2 quarters. The position peaked at $556K in Q3 2020. 200 funds tracked by Wall St. Rank hold DYN as of Q3 2024.

  • Mirabella Financial Services reported no remaining Dyne Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 5,698 Dyne Therapeutics shares in Q3 2024, an estimated $201K.
  • Mirabella Financial Services first reported a position in Dyne Therapeutics in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Dyne Therapeutics position peaked at $556K in Q3 2020.
  • 200 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.